TY - JOUR
T1 - Early growth response-1 plays an important role in ischemia-reperfusion injury in lung transplants by regulating polymorphonuclear neutrophil infiltration
AU - Yamamoto, Sumiharu
AU - Yamane, Masaomi
AU - Yoshida, Osamu
AU - Waki, Naohisa
AU - Okazaki, Mikio
AU - Matsukawa, Akihiro
AU - Oto, Takahiro
AU - Miyoshi, Shinichiro
PY - 2015/10/23
Y1 - 2015/10/23
N2 - Background. Early growth response-1 (Egr-1) has been shown to be a trigger-switch transcription factor that is involved in lung ischemia-reperfusion injury (IRI). Methods. Mouse lung transplants were performed in wild-type (WT) C57BL/6 and Egr1-knockout (KO) mice in the following donor→recipient combinations: WT→WT, KO→WT, WT→KO, and KO→KO to determine whether the presence of Egr-1 in the donor or recipient is the most critical factor for IRI. Pulmonary grafts were retrieved after 18 hours of ischemia after 4 hours of reperfusion. We analyzed graft function by analyzing arterial blood gas and histology in each combination and assessed the effects of Egr1 depletion on inflammatory cytokines that are regulated by Egr-1 as well on polymorphonuclear neutrophil (PMN) infiltration. Results. Deletion of Egr1 improved pulmonary graft function in the following order of donor→ recipient combinations: WT→ WT < WT→KO < KO→ WT < KO→ KO. Polymerase chain reaction assays for Il1B, Il6, Mcp1, Mip2, Icam1, and Cox2 showed significantly lower expression levels in the KO→KO group than in the other groups. Immunohistochemistry demonstrated clear Egr-1 expression in the nuclei of pulmonary artery endothelial cells andPMN cytoplasmin the WT grafts. Flow cytometry analysis showed that Egr1 deletion reduced PMN infiltration and that the extent of reduction correlatedwith graft function.Conclusions.Both graft and recipient Egr-1 played a role in lung IRI, but the graft side contributedmore to this phenomenon through regulation of PMN infiltration. Donor Egr-1 expression in pulmonary artery endothelial cells may play an important role in PMN infiltration, which results in IRI after lung transplantation.
AB - Background. Early growth response-1 (Egr-1) has been shown to be a trigger-switch transcription factor that is involved in lung ischemia-reperfusion injury (IRI). Methods. Mouse lung transplants were performed in wild-type (WT) C57BL/6 and Egr1-knockout (KO) mice in the following donor→recipient combinations: WT→WT, KO→WT, WT→KO, and KO→KO to determine whether the presence of Egr-1 in the donor or recipient is the most critical factor for IRI. Pulmonary grafts were retrieved after 18 hours of ischemia after 4 hours of reperfusion. We analyzed graft function by analyzing arterial blood gas and histology in each combination and assessed the effects of Egr1 depletion on inflammatory cytokines that are regulated by Egr-1 as well on polymorphonuclear neutrophil (PMN) infiltration. Results. Deletion of Egr1 improved pulmonary graft function in the following order of donor→ recipient combinations: WT→ WT < WT→KO < KO→ WT < KO→ KO. Polymerase chain reaction assays for Il1B, Il6, Mcp1, Mip2, Icam1, and Cox2 showed significantly lower expression levels in the KO→KO group than in the other groups. Immunohistochemistry demonstrated clear Egr-1 expression in the nuclei of pulmonary artery endothelial cells andPMN cytoplasmin the WT grafts. Flow cytometry analysis showed that Egr1 deletion reduced PMN infiltration and that the extent of reduction correlatedwith graft function.Conclusions.Both graft and recipient Egr-1 played a role in lung IRI, but the graft side contributedmore to this phenomenon through regulation of PMN infiltration. Donor Egr-1 expression in pulmonary artery endothelial cells may play an important role in PMN infiltration, which results in IRI after lung transplantation.
UR - http://www.scopus.com/inward/record.url?scp=84945921841&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84945921841&partnerID=8YFLogxK
U2 - 10.1097/TP.0000000000000783
DO - 10.1097/TP.0000000000000783
M3 - Article
C2 - 26079744
AN - SCOPUS:84945921841
SN - 0041-1337
VL - 99
SP - 2285
EP - 2293
JO - Transplantation
JF - Transplantation
IS - 11
ER -